| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.2M | -54.8% |
| Cost of Revenue | $8.4M | +44.8% |
| Gross Profit | -$4.3M | -224.0% |
| R&D Expense | $109.6M | +46.6% |
| SG&A Expense | $31.1M | +9.4% |
| Operating Income | -$152.0M | -45.8% |
| Pre-tax Income | -$147.3M | -44.6% |
| Income Tax | $0 | — |
| Net Income | -$147.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.4M | +0.9% |
| Short-term Investments | $256.4M | -32.2% |
| Accounts Receivable | $2.9M | +23.3% |
| Inventory | $3.0M | +43.0% |
| Current Assets | $335.1M | -26.9% |
| Total Assets | $356.6M | -25.6% |
| Current Liabilities | $21.8M | +52.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$109.9M | -33.9% |
| Capital Expenditures | $7.4M | +93.2% |
| Investing Cash Flow | $110.9M | +128.5% |
| Financing Cash Flow | -$369K | -100.1% |
| Free Cash Flow | -$117.3M | -36.5% |
| -44.6% |
| EPS (Basic) | -$0.68 | -33.3% |
| EPS (Diluted) | -$0.68 | -33.3% |
| Total Liabilities |
| $26.7M |
| +17.1% |
| Stockholders' Equity | $329.9M | -27.7% |